Literature DB >> 8334199

Myelodysplastic syndrome associated with relapsing polychondritis: unusual transformation from refractory anemia to chronic myelomonocytic leukemia.

T Shirota1, O Hayashi, H Uchida, N Tonozuka, N Sakai, H Itoh.   

Abstract

The authors report an unusual case of myelodysplastic syndrome (MDS) associated with relapsing polychondritis (RP), which developed at almost the same time as MDS. The initial diagnosis was MDS, refractory anemia (RA) subtype, according to the FAB classification. Symptoms of RP were apparently controlled by oral administration of prednisolone (PSL), although MDS was not. Within 1 month after the diagnosis, monocytosis and thrombocytopenia without excess of blasts became prominent and transformation from RA to chronic myelomonocytic leukemia (CMML) was recognized. Combination chemotherapy including daunorubicin (DNR) and cytosine arabinoside (ara-c) did not subdue the progressive monocytosis and thrombocytopenia. Finally, the patient died of pulmonary hemorrhage 3 months after the onset of the disease. The prognosis of MDS may be poorly influenced by association with RP.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8334199     DOI: 10.1007/bf01709666

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  20 in total

1.  Relapsing polychondritis: autoimmunity to type II collagen and treatment with cyclosporin A.

Authors:  A Anstey; S Mayou; K Morgan; R B Clague; D D Munro
Journal:  Br J Dermatol       Date:  1991-12       Impact factor: 9.302

2.  Relapsing polychondritis: an autoimmune disease.

Authors:  L Giroux; F Paquin; M J Guérard-Desjardins; A Lefaivre
Journal:  Semin Arthritis Rheum       Date:  1983-11       Impact factor: 5.532

3.  Clinical aspects of the myelodysplastic syndromes (MDS) with special reference to refractory anemia with excess of blasts (RAEB).

Authors:  M Omine; H Yamauchi
Journal:  Nihon Ketsueki Gakkai Zasshi       Date:  1989-07

Review 4.  Relapsing polychondritis: prospective study of 23 patients and a review of the literature.

Authors:  L P McAdam; M A O'Hanlan; R Bluestone; C M Pearson
Journal:  Medicine (Baltimore)       Date:  1976-05       Impact factor: 1.889

5.  Myelodysplastic syndromes. A clinical and pathologic analysis of 109 cases.

Authors:  K Foucar; R M Langdon; J O Armitage; D B Olson; T J Carroll
Journal:  Cancer       Date:  1985-08-01       Impact factor: 6.860

6.  Proposals for the classification of the myelodysplastic syndromes.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1982-06       Impact factor: 6.998

7.  Natural killer (NK)-cell activity and antibody-dependent cellular cytotoxicity (ADCC) in primary preleukemic syndrome.

Authors:  G Kerndrup; K Meyer; J Ellegaard; P Hokland
Journal:  Leuk Res       Date:  1984       Impact factor: 3.156

8.  Myelodysplastic syndromes: a study of 101 cases according to the FAB classification.

Authors:  T Vallespi; M Torrabadella; A Julia; D Irriguible; A Jaen; G Acebedo; J Triginer
Journal:  Br J Haematol       Date:  1985-09       Impact factor: 6.998

9.  Relapsing polychondritis: a paraneoplastic syndrome associated with myelodysplastic syndromes.

Authors:  K Van Besien; G Tricot; R Hoffman
Journal:  Am J Hematol       Date:  1992-05       Impact factor: 10.047

10.  Antibodies to type II collagen in relapsing polychondritis.

Authors:  J M Foidart; S Abe; G R Martin; T M Zizic; E V Barnett; T J Lawley; S I Katz
Journal:  N Engl J Med       Date:  1978-11-30       Impact factor: 91.245

View more
  4 in total

1.  Polychondritis Terminating in Eosinophilic Leukemia.

Authors:  Judit Várkonyi; Lajos Jakab; Attila Zalatnay; Péter Nagy; Rita Vámoss; Tamás Szombathy
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

2.  Ankylosing spondylitis in a patient with myelodysplastic syndrome: an association with HLA-B27 or coincidence?

Authors:  Jaejoon Lee; Hyungjin Kim; Joong Kyong Ahn; Ji Won Hwang; Jun Ho Jang; Eun-Mi Koh; Hoon-Suk Cha
Journal:  Rheumatol Int       Date:  2008-10-09       Impact factor: 2.631

Review 3.  Paraneoplastic rheumatic syndromes.

Authors:  H J Mitnick
Journal:  Curr Rheumatol Rep       Date:  2000-04       Impact factor: 4.686

Review 4.  Hematological malignancies mimicking rheumatic syndromes: case series and review of the literature.

Authors:  Gil Bornstein; Nadav Furie; Nimrod Perel; Ilan Ben-Zvi; Chagai Grossman
Journal:  Rheumatol Int       Date:  2018-07-18       Impact factor: 3.580

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.